ROSETTA GENOMICS LTD.
October 25, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Irene Paik
Re: | Rosetta Genomics Ltd. (the “Company”) |
Registration Statement on Form F-1 (the “Registration Statement”)
Filed October 16, 2017
File No. 333-220985
Dear Madam:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Rosetta Genomics Ltd. (the “Company”), hereby requests that the effective date and time of the above-referenced registration statement (the “Registration Statement”) be accelerated to October 27, 2017, at5:00 p.m., Eastern Time, or at such later time as the Company or its counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). We respectfully request that a copy of the written order from the Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., Attention: Robert E. Burwell, by facsimile to (415) 432-6001 or by email to REBurwell@mintz.com.
The cooperation of the staff in meeting the timetable described above is very much appreciated. Please call Robert E. Burwell of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. at (415) 432-6107 with any comments or questions regarding the Registration Statement.
Very truly yours,
/s/ Ken Berlin
Kenneth A. Berlin
CEO and President